发明名称 |
ORALLY DISINTEGRABLE TABLET |
摘要 |
Provided is an orally disintegrable tablet that shows a high stability of active ingredients [acetylsalicylic acid and a proton pump inhibitor (PPI)] and stably and quickly exerts the pharmacological effects of the active ingredients after dosing. A multiple unit-type orally disintegrable tablet that comprises enteric microgranules containing acetylsalicylic acid, enteric microgranules containing a PPI and additives, wherein an enteric coating layer of the enteric microgranules containing acetylsalicylic acid contains an aqueous enteric polymer base and a sustained-release base. |
申请公布号 |
PH12015502578(A1) |
申请公布日期 |
2016.02.29 |
申请号 |
PH12015502578 |
申请日期 |
2015.11.13 |
申请人 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED |
发明人 |
KAWANO, TETSUYA;ISHII, YUMIKO |
分类号 |
A61K31/4439;A61K9/26;A61K31/616;A61K45/08;A61K47/10;A61K47/32;A61P1/04 |
主分类号 |
A61K31/4439 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|